NCT01984502View on ClinicalTrials.gov

CyberKnife Accelerated Hemilarynx Stereotactic Radiotherapy Study for Early-stage Glottic Larynx Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

November 18, 2013

Primary Completion Date

May 31, 2022

Study Completion Date

May 31, 2022

Conditions
Early-stage Glottic Larynx Cancer
Interventions
RADIATION

CyberKnife Accelerated Hemilarynx Stereotactic Radiotherapy

CyberKnife Accelerated Hemilarynx Stereotactic Radiotherapy

Trial Locations (1)

75239

University Of Texas Southwestern Medical Center, Dallas

All Listed Sponsors
lead

University of Texas Southwestern Medical Center

OTHER

NCT01984502 - CyberKnife Accelerated Hemilarynx Stereotactic Radiotherapy Study for Early-stage Glottic Larynx Cancer | Biotech Hunter | Biotech Hunter